Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Jiangsu Recbio Technology Co., Ltd. Class H ( (HK:2179) ) has shared an announcement.
Jiangsu Recbio Technology Co., Ltd. has announced a board meeting scheduled for March 28, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024. The meeting will also consider the potential payment of a final dividend, which could impact the company’s financial distribution to its stakeholders.
More about Jiangsu Recbio Technology Co., Ltd. Class H
Jiangsu Recbio Technology Co., Ltd. is a joint stock company based in the People’s Republic of China, operating within the biotechnology industry. The company focuses on developing and providing innovative biotechnological solutions and products.
YTD Price Performance: -17.05%
Average Trading Volume: 93,969
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: HK$3.72B
See more insights into 2179 stock on TipRanks’ Stock Analysis page.